- Ovarian Cancer: The Not-So Silent Killer
Ovarian cancer doesn’t get the kind of attention breast cancer gets. It’s not as common, and because survival rates are poor, it does not produce an army of survivors to raise awareness. It’s traditionally known as the “silent killer” because it was thought to reveal no symptoms in its earliest, most curable stages.
- Congestive Heart Failure Is Rare Among Leukemia Patients Who Take Imatinib
Congestive heart failure rarely occurs among leukemia patients who take imatinib, researchers at The University of Texas M. D. Anderson Cancer Center found after an exhaustive review of the detailed medical histories of 1,276 patients who enrolled in clinical trials for the drug.
- Prevention Of Primary Variceal Bleeding
Beta blockers should be the first line of prevention against variceal bleeding in patients with cirrhosis and portal hypertension. While banding is similarly effective in reducing the incidence of such bleeding, it can have fatal complications and is more expensive.
- Link Found Between A Lack Of Vitamin D And Pre-Eclampsia
Researchers in the United States have found an association between vitamin D levels in pregnant women and the risk of pre-eclampsia; they say women who have a vitamin D deficiency early in their pregnancy are at risk from pre-eclampsia.
- Promising Drug Combination May Help Those With Ocular Melanoma That Has Spread
A combination of two drugs shows promise in treating a rare and therapy-resistant type of melanoma that originates in the eye and spreads to other organs, according to a new study led by Duke University Comprehensive Cancer Center researchers.
- Early Allergy Diagnoses Are Associated With A Reduced Risk Of Acute Lymphoblastic Leukaemia
Children who receive a definite diagnosis of allergy in early life have a 20% reduced risk of developing acute lymphoblastic leukemia (ALL).